Related Experiment Videos

Reduction of cardiovascular structural changes by nifedipine GITS in essential hypertensive patients

E Agabiti-Rosei1, R Zulli, M L Muiesan

  • 1Semeiotica and Metodologia Medica, UOP Scienze Mediche, University of Brescia, Italy.

Blood Pressure
|October 3, 1998
PubMed

Insights

Nifedipine GITS and hydrochlorothiazide effectively lower blood pressure in hypertensive patients with left ventricular hypertrophy. Nifedipine GITS demonstrated a greater reduction in minimal vascular resistance and left ventricular mass index compared to hydrochlorothiazide.

Area of Science:

  • Cardiology
  • Pharmacology
  • Hypertension Research

Background:

  • Essential hypertension is often associated with left ventricular hypertrophy (LVH).
  • Left ventricular mass and vascular resistance are key indicators of cardiovascular risk in hypertensive patients.

Purpose of the Study:

  • To compare the effects of Nifedipine GITS and hydrochlorothiazide (HCTZ) on reducing left ventricular mass and minimal vascular resistance in essential hypertensives with LVH.
  • To analyze the impact on blood pressure and echocardiographic LV functional parameters.

Main Methods:

  • Double-blind, randomized comparison of Nifedipine GITS versus HCTZ.
  • Echocardiography used to measure left ventricular mass index (LVMI).
  • Strain gauge plethysmography used to measure forearm minimal vascular resistance.

Main Results:

  • Both Nifedipine GITS and HCTZ significantly reduced systolic and diastolic blood pressure.
  • Nifedipine GITS monotherapy showed a progressive decrease in LVMI over 24 weeks.
  • Nifedipine GITS monotherapy significantly reduced minimal vascular resistance, with a greater effect than HCTZ.

Conclusions:

  • Nifedipine GITS, alone or combined with HCTZ, significantly reduces LVMI and vascular structural changes in hypertensive patients with LVH.
  • Nifedipine GITS monotherapy offers a superior reduction in minimal vascular resistance compared to HCTZ monotherapy.

Related Concept Videos